Cardiol Therapeutics (CRDL) Competitors C$1.80 -0.06 (-3.23%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock CRDL vs. NVO, DNA, TLRY, VBV, CUS, AIM, FRX, ITH, IPA, and APMShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), Tilray Brands (TLRY), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), International Tower Hill Mines (ITH), ImmunoPrecise Antibodies (IPA), and Andean Precious Metals (APM). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Its Competitors Novo Resources Corp. (NVO.V) Dalradian Resources Tilray Brands VBI Vaccines Chemtrade Electrochem Inc, Aimia Fennec Pharmaceuticals International Tower Hill Mines ImmunoPrecise Antibodies Andean Precious Metals Novo Resources Corp. (NVO.V) (CVE:NVO) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Does the media prefer NVO or CRDL? In the previous week, Cardiol Therapeutics had 1 more articles in the media than Novo Resources Corp. (NVO.V). MarketBeat recorded 1 mentions for Cardiol Therapeutics and 0 mentions for Novo Resources Corp. (NVO.V). Novo Resources Corp. (NVO.V)'s average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score. Company Overall Sentiment Novo Resources Corp. (NVO.V) Neutral Cardiol Therapeutics Neutral Do institutionals and insiders believe in NVO or CRDL? 11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, NVO or CRDL? Novo Resources Corp. (NVO.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovo Resources Corp. (NVO.V)N/AN/AN/A-C$0.11-21.25Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-3.54 Is NVO or CRDL more profitable? Novo Resources Corp. (NVO.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Novo Resources Corp. (NVO.V)N/A N/A N/A Cardiol Therapeutics N/A -195.07%-54.15% SummaryCardiol Therapeutics beats Novo Resources Corp. (NVO.V) on 4 of the 7 factors compared between the two stocks. Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$149.36MC$2.20BC$5.51BC$6.20BDividend YieldN/A2.92%5.25%6.72%P/E Ratio-3.544.1227.4650.46Price / SalesN/A562.63366.991,212.93Price / Cash0.9810.3537.5083.29Price / Book12.0511.478.034.71Net Income-C$42.93MC$21.15BC$3.17BC$301.20M7 Day Performance-13.04%0.66%3.75%1.06%1 Month Performance-5.76%6.62%3.76%4.14%1 Year Performance-36.84%2.11%29.84%26.71% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol TherapeuticsN/AC$1.80-3.2%N/A-32.4%C$149.36MN/A-3.5420NVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400DNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640TLRYTilray BrandsN/AC$0.58+3.6%N/A-65.5%C$373.73MC$610.34M-1.402,650News CoverageVBVVBI VaccinesN/AN/AN/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AN/AN/AN/AC$306.50MN/A0.0060AIMAimia2.5101 of 5 starsC$2.76+1.5%C$4.00+44.9%+18.0%C$265.45MC$464.71M-3.4020Positive NewsFRXFennec PharmaceuticalsN/AC$11.69+3.5%N/A+54.7%C$225.44MC$34.86M-198.0310News CoverageGap UpITHInternational Tower Hill MinesN/AC$1.20+2.6%N/A+91.9%C$168.48MN/A-50.13220News CoverageGap UpIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap DownAPMAndean Precious Metals2.5586 of 5 starsC$1.29+7.5%C$2.00+55.0%+29.0%C$135.47MC$154.78M2.5530 Related Companies and Tools Related Companies Novo Resources Corp. (NVO.V) Alternatives Dalradian Resources Alternatives Tilray Brands Alternatives VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives Fennec Pharmaceuticals Alternatives International Tower Hill Mines Alternatives ImmunoPrecise Antibodies Alternatives Andean Precious Metals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRDL) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
